Omega-3 polyunsaturated fatty acids (PUFAs) are long-chain fatty acids that have been extensively studied for their role in cardiovascular and metabolic health. Increasingly, evidence also highlights their influence on brain function and mental health outcomes. The two principal omega-3s of clinical relevance are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), both of which are found in marine sources such as oily fish. A third, alpha-linolenic acid (ALA), is plant-derived and can be converted into EPA and DHA, although conversion rates are low in humans.
Given that nearly 60% of the brain is composed of lipids, with DHA being a structural component of neuronal membranes, it is not surprising that deficiencies in omega-3 fatty acids have been linked with mood disorders, cognitive dysfunction, and neurodevelopmental conditions.
Biological Mechanisms Linking Omega-3s to Mental Health
1. Cell Membrane Fluidity and Neurotransmission
DHA is highly concentrated in neuronal cell membranes, where it contributes to membrane fluidity. This property is essential for optimal receptor function and neurotransmitter signalling, including serotonin and dopamine pathways implicated in mood regulation.
2. Inflammatory Pathways
EPA, in particular, exerts anti-inflammatory effects by reducing pro-inflammatory cytokine production and promoting the synthesis of specialised pro-resolving mediators (SPMs). Chronic, low-grade neuroinflammation is increasingly recognised as a factor in depression and other mental health conditions.
3. Regulation of the Hypothalamic-Pituitary-Adrenal (HPA) Axis
Omega-3 fatty acids have been shown to modulate stress responses by influencing cortisol secretion. Dysregulation of the HPA axis is a well-established contributor to anxiety and mood disorders.
4. Neuroplasticity and Neurogenesis
Omega-3s, particularly DHA, support the expression of brain-derived neurotrophic factor (BDNF), a protein essential for neuroplasticity, learning, and memory. Low BDNF levels are associated with depression and cognitive decline.
Evidence from Clinical Research
Depression
Numerous randomised controlled trials (RCTs) and meta-analyses have found that supplementation with omega-3s, especially EPA-dominant formulations, can reduce depressive symptoms. The effect appears strongest in individuals with elevated inflammatory markers, suggesting a role for targeted therapy.
Anxiety Disorders
Although findings are more variable than in depression, several studies indicate that omega-3 supplementation can lower perceived stress and anxiety scores. Mechanisms likely include modulation of neurotransmission and reduced neuroinflammation.
Attention-Deficit/Hyperactivity Disorder (ADHD)
Children and adults with ADHD often present with lower circulating levels of omega-3s. Supplementation, particularly with DHA, has demonstrated modest improvements in attention, working memory, and behavioural outcomes.
Cognitive Decline and Neurodegenerative Disease
Prospective cohort studies and clinical trials suggest that higher omega-3 intake is associated with reduced risk of Alzheimer’s disease and slower progression of cognitive decline. DHA appears to play a protective role in maintaining synaptic integrity.
Dietary Sources and Supplementation
-
Food Sources: Oily fish such as salmon, sardines, mackerel, herring, and anchovies provide the richest sources of EPA and DHA. Plant foods such as flaxseeds, chia seeds, and walnuts contain ALA but rely on inefficient enzymatic conversion.
-
Supplementation: For mental health outcomes, EPA-dominant supplements (with a typical EPA:DHA ratio of 2:1) are often studied. Clinical benefits have been observed with dosages of 1–2 g of EPA per day. Algal oil offers a suitable alternative for vegetarians and vegans.
-
Safety: High-quality supplements should be purified to remove heavy metals and tested for oxidation. Doses above 3 g/day should be supervised by a clinician due to potential anticoagulant effects.
The influence of omega-3 fatty acids on mental health is supported by both mechanistic and clinical evidence. Through effects on membrane structure, neurotransmission, inflammation, and neuroplasticity, EPA and DHA contribute to mood regulation, stress response, cognitive function, and neuroprotection. While omega-3 supplementation is not a substitute for conventional psychiatric care, it represents a valuable adjunctive strategy within an integrative mental health framework.
You can find out more about testing omega-3 fatty acid levels here.




